CS
TERN

Credit Suisse’s Terns Pharmaceuticals TERN Stock Holding History

Credit Suisse’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$223K Hold
33,949
– – ﹤0.01% 2886
2023
Q4 		$220K Buy
33,949
+1,827
+6% +$9.66K ﹤0.01% 2966
2023
Q3 		$162K Sell
32,122
-1,665
-5% -$10.6K ﹤0.01% 3059
2023
Q2 		$296K Buy
+33,787
New +$394K ﹤0.01% 3007
2022
Q3 		– Sell
-7
Closed – – 4283
2022
Q2 		$0 Buy
+7
New +$14 ﹤0.01% 4307

Other funds holding TERN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Credit Suisse's TERN Position: Q1 2024 in Review

Credit Suisse held its Terns Pharmaceuticals (TERN) position steady in Q1 2024 at 33,949 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

Credit Suisse first reported a position in TERN in Q2 2022 and has held it in 5 quarters since. The position peaked at $296K in Q2 2023. 112 funds tracked by Wall St. Rank hold TERN as of Q1 2024.

  • Credit Suisse held 33,949 shares of Terns Pharmaceuticals worth $223K as of Q1 2024.
  • Credit Suisse left its Terns Pharmaceuticals share count unchanged in Q1 2024.
  • Terns Pharmaceuticals made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2886 holding.
  • Credit Suisse first reported a position in Terns Pharmaceuticals in Q2 2022 and has held it in 5 quarters since.
  • Credit Suisse's Terns Pharmaceuticals position peaked at $296K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.